- 1 update
A new, more natural IVF treatment offering hope for women at risk of life-threatening complications from traditional fertility treatments has been pioneered at London's Hammersmith Hospital.
The study, conducted in conjunction with Imperial College London, tested the use of a naturally occurring hormone, kisspeptin, to induce egg development.
This allows women to avoid the use of traditional IVF drugs which can trigger a serious condition called ovarian hyperstimulation syndrome.
The women most at risk are those with polycystic ovary syndrome.
The study proved that kisspeptin can be successfully used in IVF treatment, with the first baby, a healthy boy, being born in April.